Blake D. Anson - Publications, H-index & Citations

Blake D. Anson

AstraZeneca

26H指数

87论文数

3.6K被引数

收录论文 19

发表时间

Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study

TOXICOLOGICAL SCIENCES

IF4.1

2018-04-27

OAAI

Millard, Daniel; Dang, Qianyu; Shi, Hong; Zhang, Xiaou; Strock, Chris; Kraushaar, Udo; Zeng, Haoyu; Levesque, Paul; Lu, Hua-Rong; Guillon, Jean-Michel; Wu, Joseph C.; Li, Yingxin; Luerman, Greg; Anson, Blake; Guo, Liang; Clements, Mike; Abassi, Yama A.; Ross, James; Pierson, Jennifer; Gintant, Gary

Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery

CELL CHEMICAL BIOLOGY

IF7.2

2017-05-01

OAAI

Drawnel, Faye Marie; Zhang, Jitao David; Kung, Erich; Aoyama, Natsuyo; Benmansour, Fethallah; Del Rosario, Andrea Araujo; Zoffmann, Sannah Jensen; Delobel, Frederic; Prummer, Michael; Weibel, Franziska; Carlson, Coby; Anson, Blake; Iacone, Roberto; Certa, Ulrich; Singer, Thomas; Ebeling, Martin; Prunotto, Marco

In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2017-05-01

OAAI

Sirenko, Oksana; Grimm, Fabian A.; Ryan, Kristen R.; Iwata, Yasuhiro; Chiu, Weihsueh A.; Parham, Frederick; Wignall, Jessica A.; Anson, Blake; Cromwell, Evan F.; Behl, Mamta; Rusyn, Ivan; Tice, Raymond R.

Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived Cardiomyocytes

TOXICOLOGICAL SCIENCES

IF4.1

2016-08-07

PREAI

Millard, Daniel C.; Strock, Christopher J.; Carlson, Coby B.; Aoyama, Natsuyo; Juhasz, Krisztina; Goetze, Tom A.; Stoelzle-Feix, Sonja; Becker, Nadine; Fertig, Niels; January, Craig T.; Anson, Blake D.; Ross, James D.

Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2015-12-18

OAAI

Drowley, Lauren; Koonce, Chad; Peel, Samantha; Jonebring, Anna; Plowright, Alleyn T.; Kattman, Steven J.; Andersson, Henrik; Anson, Blake; Swanson, Bradley J.; Wang, Qing-Dong; Brolen, Gabriella

Human iPS Cell-Derived Cardiomyocytes Carrying MHC-R403Q Exhibit Aspects of Hypertrophic Cardiomyopathy in vitro

BIOPHYSICAL JOURNAL

IF3.1

2015-01-01

OAAI

Jones, Eugenia; Carlson, Coby B.; Koonce, Chad; Aoyama, Natsuyo; Wang, Jun; Meline, Benjamin; Kattman, Steven J.; Anson, Blake

Combine use of Intracellular Calcium and Sarcolemma Voltage Measurements to Distinguish Mixed Channel Effects in Human Induced Plutipotent Stem Cells Derived Cardiomyocytes (HIPSC-CMS)

BIOPHYSICAL JOURNAL

IF3.1

2014-01-01

OAAI

Hortigon-Vinagre, Maria P.; Low, Emma L.; Ghouri, Iffath A.; Wallis, Robert; Burton, Francis L.; Craig, Margaret A.; Anson, Blake D.; Smith, Godfrey L.

Comparative Gene Expression Profiling in Human-Induced Pluripotent Stem Cell-Derived Cardiocytes and Human and Cynomolgus Heart Tissue

TOXICOLOGICAL SCIENCES

IF4.1

2012-09-14

OAAI

Puppala, Dinesh; Collis, Leon P.; Sun, Sunny Z.; Bonato, Vinicius; Chen, Xian; Anson, Blake; Pletcher, Mathew; Fermini, Bernard; Engle, Sandra J.

Characterization of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Bioenergetics and Utilization in Safety Screening

TOXICOLOGICAL SCIENCES

IF4.1

2012-07-27

160

OAAI

Rana, Payal; Anson, Blake; Engle, Sandra; Will, Yvonne

Opportunities for Use of Human iPS Cells in Predictive Toxicology

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2011-03-23

132

OAAI

Anson, B. D.; Kolaja, K. L.; Kamp, T. J.

Mechanism Of IKr Loss In Mutant T421M-hERG Expressing Rat Ventricular Myocytes

BIOPHYSICAL JOURNAL

IF3.1

2009-02-01

OAAI

Balijepalli, Sadguna Y.; Tester, David J.; Wang, Jing; Holzem, Kassandra E.; Chew, Chen Li; Anson, Blake D.; Kamp, Timothy J.; Ackerman, Michael J.; January, Craig T.

Comparison of HERG channel blocking effects of various β-blockers -: implication for clinical strategy

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-30

OAAI

Kawakami, K; Nagatomo, T; Abe, H; Kikuchi, K; Takemasa, H; Anson, BD; Delisle, BP; January, CT; Nakashima, Y

Drug-induced long QT syndrome:: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine 药物引起的长QT综合征:: 氟西汀和去甲氟西汀对hERG K通道的阻滞和蛋白质运输的破坏

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-29

187

OAAI

Rajamani, S.; Eckhardt, L. L.; Valdivia, C. R.; Klemens, C. A.; Gillman, B. M.; Anderson, C. L.; Holzem, K. M.; Delisle, B. P.; D Anson, B.; Makielski, J. C.; January, C. T.

Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism

CIRCULATION

IF38.6

2006-01-24

387

OAAI

Anderson, CL; Delisle, BP; Anson, BD; Kilby, JA; Will, ML; Tester, DJ; Gong, QM; Zhou, ZF; Ackerman, MJ; January, CT

Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome

MOLECULAR PHARMACOLOGY

IF3

2005-07-01

PREAI